Results 41 to 50 of about 118,801 (189)

Helicobacter pylori: types of diseases, diagnosis, treatment and causes of therapeutic failure [PDF]

open access: yes, 2016
Acute upper gastrointestinal lesions have a multifactorial etiology but, regardless of the cause, they are related to mucosal barrier destruction. Since Helicobacter pylori induces a superficial chronic gastritis with the infiltration of neutrophils in ...
Ciorbagiu, Mihai Calin   +5 more
core   +3 more sources

Caveolin-1 protects B6129 mice against Helicobacter pylori gastritis. [PDF]

open access: yes, 2013
Caveolin-1 (Cav1) is a scaffold protein and pathogen receptor in the mucosa of the gastrointestinal tract. Chronic infection of gastric epithelial cells by Helicobacter pylori (H. pylori) is a major risk factor for human gastric cancer (GC) where Cav1 is
A Bist   +103 more
core   +4 more sources

Upstream stimulating factor 1 (USF1) -202 G/A polymorphism and serum levels of USF1 and USF2 are associated with gastric cancer risk: a case control study

open access: yesJournal of Cancer Research and Clinical Oncology
Purpose Gastric cancer is an inflammation-driven disease often associated with a bad prognosis. Upstream stimulatory factors USF1 and USF2 are pleiotropic transcription factors, with tumor suppressor function.
Ghizlane Bounder   +8 more
doaj   +1 more source

Antimicrobial-Resistance Profile of Helicobacter pylori, Obtained from Endoscopic Patients in Bahir Dar, North West Ethiopia

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2023
Background. Antimicrobial resistance for Helicobacter pylori infection is a highly emerging problem throughout the world to treat gastric-associated diseases.
Mulat Erkihun   +2 more
doaj   +1 more source

Bismuth-based quadruple therapy following H. Pylori eradication failures: A multicenter study in clinical practice [PDF]

open access: yes, 2015
Background & Aims: Helicobacter pylori (H. pylori) eradication in patients who failed one or more therapeutic attempts remains challenging. This study aimed to assess the efficacy of three-in-one capsules bismuth-based quadruple therapy (Pylera®) in ...
Zullo, Angelo   +16 more
core   +5 more sources

Revealing the pathogenesis of gastric intestinal metaplasia based on the mucosoid air-liquid interface

open access: yesJournal of Translational Medicine
Background Gastric intestinal metaplasia (GIM) is an essential precancerous lesion. Although the reversal of GIM is challenging, it potentially brings a state-to-art strategy for gastric cancer therapeutics (GC).
Simeng Liu   +11 more
doaj   +1 more source

Global Trend on Machine Learning in Helicobacter within One Decade: A Scientometric Study

open access: yesGlobal Health, Epidemiology and Genomics, 2023
Purpose. This study aims to create a science map, provide structural analysis, investigate evolution, and identify new trends in Helicobacter pylori (H. pylori) research articles. Methods.
Omid Eslami   +6 more
doaj   +1 more source

The persistence of Epstein-Barr virus in the gastric mucosa in patients with chronic Helicobacter pylori-induced gastritis with gastric erosions and the effect on the course of the disease depending on the therapy

open access: yesЛечащий Врач, 2021
The leading etiological factor of chronic gastritis is Helicobacter pylori infection. Herpesvirus infection can take part in the development and maintenance of the inflammatory process in the gastric mucosa.
E. E. Dubskaya   +2 more
doaj   +1 more source

Study of association between helicobacter pylori infection and microalbuminuria in type-2 diabetic patients [PDF]

open access: yes, 2015
BACKGROUND/AIMS: As default, Helicobacter pylori infection may cause systemic inflammation and vascular endothelial damage. Therefore, it can be assumed that the glomerular damage as a result may lead to an increase in urinary albumin excretion. In this
Moghni, M., Reiisi, S., Shahi, H.
core  

Helicobacter pylori infection: the reduced need for ulcer surgery [PDF]

open access: yes, 1999
The success of the eradication treatment for Helicobacter pylori in managing ulcer disease has further refined the indications for ulcer surgery. More patients are spared unnecessary surgery and its untoward sequelae.
Chu, KM
core  

Home - About - Disclaimer - Privacy